Skip to main content
. 2016 Sep 22;34(41):4979–4984. doi: 10.1016/j.vaccine.2016.08.032

Fig. 1.

Fig. 1

Seroprevalence of anti-poliovirus type 3 antibodies by number of OPV doses compared with binomial maximum likelihood model. Estimates reported by John TJ 1976 [16] from the same area are shown by way of comparison.